Cerebrovascular Assessment for the Risk Prediction of Alzheimer's Disease

被引：30

作者：

Silvestrini, Mauro ^{[1
]}

Viticchi, Giovanna ^{[1
]}

Altamura, Claudia ^{[2
]}

Luzzi, Simona ^{[1
]}

Balucani, Clotilde ^{[3
]}

Vernieri, Fabrizio ^{[2
]}

机构：

[1] Univ Politecn Marche, Neurol Clin, I-60020 Ancona, Italy

[2] Campus Biomed Univ, Neurol Clin, Rome, Italy

[3] Suny Downstate Med Ctr, Dept Neurol, Brooklyn, NY 11203 USA

来源：

JOURNAL OF ALZHEIMERS DISEASE | 2012年 / 32卷 / 03期

关键词：

Alzheimer's disease; vascular markers; vascular risk factors; WHITE-MATTER LESIONS; MILD COGNITIVE IMPAIRMENT; INTIMA-MEDIA THICKNESS; CEREBRAL VASOMOTOR REACTIVITY; GLYCATION END-PRODUCTS; MIDLIFE BLOOD-PRESSURE; APOLIPOPROTEIN-E; CAROTID ATHEROSCLEROSIS; AMYLOID-BETA; ATRIAL-FIBRILLATION;

D O I：

10.3233/JAD-2012-121240

中图分类号：

Q189 [神经科学];

学科分类号：

071006 ;

摘要：

Increasing evidence is emerging that vascular disease and its risk factors play a role in the development of Alzheimer's disease (AD) and affect the probability of an adverse outcome. The aims of this review are to explore the relationship between vascular risk factors and AD and to discuss the potential use of vascular markers in the clinical approach to cognitive impairment. Moreover, we present evidence about the potential use of ultrasonographic and neuroradiologic markers of cognitive impairment in order to establish possible treatment strategies in subjects with a clinical profile at risk of developing AD.

引用

页码：689 / 698

页数：10

共 50 条

[21] Apolipoprotein E genotype and risk of ischemic cerebrovascular disease, Alzheimer's disease, and vascular dementia
Frikke-Schmidt, R
Nordestgaard, BG
Thudium, D
Groenholdt, MLM
Tybjaerg-Hansen, A
CIRCULATION, 1999, 100 (18) : 532 - 532
[22] CEREBROVASCULAR AND CARDIOVASCULAR PATHOLOGY IN ALZHEIMER'S DISEASE
de la Torre, Jack C.
NEUROBIOLOGY OF DEMENTIA, 2009, 84 : 35 - +
[23] Alzheimer's disease and driving: Prediction and assessment of driving performance
Fox, GK
Bowden, SC
Bashford, GM
Smith, DS
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 1997, 45 (08) : 949 - 953
[24] Polygenic risk and hazard scores for Alzheimer's disease prediction
Leonenko, Ganna
Sims, Rebecca
Shoai, Maryam
Frizzati, Aura
Bossu, Paola
Spalletta, Gianfranco
Fox, Nick C.
Williams, Julie
Hardy, John
Escott-Price, Valentina
Tsolaki, Magda
Craig, David
Avramidou, Despoina
Germanou, Antonia
Koutroumani, Maria
Gkatzima, Olymbia
Hampel, Harald
Kehoe, Patrick G.
Love, Seth
Rubinsztein, David C.
Frolich, Lutz
McGuinness, Bernadette
Johnston, Janet A.
Passmore, Peter
Drichel, Dmitriy
Rossor, Martin
Schott, Jonathan M.
Warren, Jason D.
Bras, Jose
Guerreiro, Rita
Kawalia, Amit
Hughes, Joseph T.
Patel, Yogen
Lupton, Michelle K.
Proitsi, Petra
Powell, John
Kauwe, John S. K.
Mancuso, Michelangelo
Bonuccelli, Ubaldo
Uphill, James
Fisher, Elizabeth
Masullo, Carlo
Soininen, Hilkka
Bisceglio, Gina
Ma, Li
Dickson, Dennis W.
Graff-Radford, Neill R.
Carrasquillo, Minerva M.
Younkin, Steven G.
Sorbi, Sandro
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY, 2019, 6 (03): : 456 - 465
[25] Imaging interactions between Alzheimer's disease and cerebrovascular disease
Wu, CC
Mungas, D
Eberling, JL
Reed, BR
Jagust, WJ
ALZHEIMER'S DISEASE: VASCULAR ETIOLOGY AND PATHOLOGY, 2002, 977 : 403 - 410
[26] Cerebrovascular disease, amyloid, and neurodegeneration in Alzheimer's disease progression
Lao, Patrick
JOURNAL OF NUCLEAR MEDICINE, 2018, 59
[27] Cerebrovascular disease promotes tau pathology in Alzheimer's disease
Laing, Krystal K.
Simoes, Sabrina
Baena-Caldas, Gloria P.
Lao, Patrick J.
Kothiya, Milankumar
Igwe, Kay C.
Chesebro, Anthony G.
Houck, Alexander L.
Pedraza, Lina
Hernandez, A. Ivan
Li, Jie
Zimmerman, Molly E.
Luchsinger, Jose A.
Barone, Frank C.
Moreno, Herman
Brickman, Adam M.
BRAIN COMMUNICATIONS, 2020, 2 (02)
[28] Cerebrovascular disease and alzheimer's disease neuropathology in multiple sclerosis
Kaplan, T.
Ouyang, B.
Stefoski, D.
Shoemaker, T.
Ko, M.
De Jager, P.
Nag, S.
Bennett, D.
Arvanitakis, Z.
Morales, F. Sierra
MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 330 - 330
[29] Evaluation of a Genetic Risk Score to Improve Risk Prediction for Alzheimer's Disease
Chouraki, Vincent
Reitz, Christiane
Maury, Fleur
Bis, Joshua C.
Bellenguez, Celine
Yu, Lei
Jakobsdottir, Johanna
Mukherjee, Shubhabrata
Adams, Hieab H.
Choi, Seung Hoan
Larson, Eric B.
Fitzpatrick, Annette
Uitterlinden, Andre G.
de Jager, Philip L.
Hofman, Albert
Gudnason, Vilmundur
Vardarajan, Badri
Ibrahim-Verbaas, Carla
van der Lee, Sven J.
Lopez, Oscar
Dartigues, Jean-Francois
Berr, Claudine
Amouyel, Philippe
Bennett, David A.
van Duijn, Cornelia
DeStefano, Anita L.
Launer, Lenore J.
Ikram, M. Arfan
Crane, Paul K.
Lambert, Jean-Charles
Mayeux, Richard
Seshadri, Sudha
JOURNAL OF ALZHEIMERS DISEASE, 2016, 53 (03) : 921 - 932
[30] The influence of ''silent'' cerebrovascular disease on measurement in Alzheimer's disease
Lawlor, BA
Swanwick, G
Coen, R
Walsh, JB
Coakley, D
BIOLOGICAL PSYCHIATRY, 1996, 39 (07) : 540 - 540

← 1 2 3 4 5 →